EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Berberine chloride suppresses pancreatic adenocarcinoma proliferation and growth by targeting inflammation-related genes: an in silico analysis with in vitro and vivo validation

Lin-Jie Ruan, Ju-Ying Jiao, Chienshan Cheng, Yuan Zhang, Zhang-Qi Cao, Ba He, Zhen Chen

Cancer Chemotherapy and Pharmacology · 2024-08 · 94 (2) · 169-181

DOI: 10.1007/s00280-024-04663-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Chemotherapy and Pharmacology, online erschienen am 19.03.2024. Verfasst von Lin-Jie Ruan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Oncology, Fudan University Shanghai Cancer Center, No. 270 Dongan Rd., Xuhui district, Shanghai, China. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Berberine, Cell Proliferation, Molecular Docking Simulation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Targeting inflammatory crosstalk between tumors and their microenvironment has emerged as a crucial method for suppressing pancreatic adenocarcinoma (PAAD) progression. Berberine (BBR) is a natural pentacyclic isoquinoline alkaloid known for its anti-inflammatory and antitumor pharmacological effects; however, the mechanism underlying PAAD suppression remains unclear. We aim to investigate the effects of BBR on PAAD progression and their underlying mechanisms.

Methods

The prognostic value of inflammation-related genes in PAAD was assessed using bioinformatics analyses, then the pharmacological effects and potential mechanisms of BBR on PAAD will be investigated in silico, in vitro, and in vivo.

Results

Fifty-eight prognostic inflammation-related genes were identified in PAAD, which were shown to have good sensitivity and specificity using a novel inflammation-related gene risk-prognosis prediction model. Among these, four candidate genes ( CAPS3, PTGS2, ICAM1 , and CXCR4 ) were predicted as targets of BBR in PAAD in silico. Molecular docking simulations showed that the four key targets docked well with BBR. Further BBR treatment suppressed cell proliferation, colony formation, and induced cell cycle arrest in vitro. Moreover, BBR exhibited a significant tumor-suppressive effect in murine subcutaneous xenografts without macroscopic hepatic and renal toxicities. In addition, BBR downregulated CAPS3 , PTGS2 , ICAM1 , and CXCR4 protein expression.

Conclusion

This study not only elucidated the prognostic value of inflammation-related genes in PAAD but also demonstrated the potential of BBR to inhibit PAAD by targeting these genes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsBerberineCell ProliferationMolecular Docking SimulationAdenocarcinomaHumansAnimalsMiceCell Line, TumorXenograft Model Antitumor AssaysInflammationComputer SimulationMice, NudeGene Expression Regulation, NeoplasticReceptors, CXCR4Mice, Inbred BALB CNerve Tissue ProteinsPrognosis

Stichwörter der Autor:innen

Molecular mechanismNetwork pharmacologyTumor microenvironmentTumor suppression

Substanzen

BerberineReceptors, CXCR4CXCR4 protein, humanNerve Tissue Proteins

Autor:innen und Institutionen

  • Department of Integrative Oncology, Fudan University Shanghai Cancer Center, No. 270 Dongan Rd., Xuhui district, Shanghai, China.
  • Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Department of Integrative Oncology, Fudan University Shanghai Cancer Center, No. 270 Dongan Rd., Xuhui district, Shanghai, China. zchenzl@fudan.edu.cn.
  • Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. zchenzl@fudan.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Ruan, L. J., Jiao, J. Y., Cheng, C., Zhang, Y., Cao, Z. Q., He, B., & Chen, Z. (2024). Berberine chloride suppresses pancreatic adenocarcinoma proliferation and growth by targeting inflammation-related genes: an in silico analysis with in vitro and vivo validation. Cancer Chemotherapy and Pharmacology, 94(2), 169-181. https://doi.org/10.1007/s00280-024-04663-7

Vancouver

Ruan LJ, Jiao JY, Cheng C, Zhang Y, Cao ZQ, He B, et al. Berberine chloride suppresses pancreatic adenocarcinoma proliferation and growth by targeting inflammation-related genes: an in silico analysis with in vitro and vivo validation. Cancer Chemotherapy and Pharmacology. 2024;94(2):169-181. doi:10.1007/s00280-024-04663-7

BibTeX
@article{Ruan2024,
  author = {Ruan, Lin-Jie and Jiao, Ju-Ying and Cheng, Chienshan and Zhang, Yuan and Cao, Zhang-Qi and He, Ba and Chen, Zhen},
  title = {Berberine chloride suppresses pancreatic adenocarcinoma proliferation and growth by targeting inflammation-related genes: an in silico analysis with in vitro and vivo validation},
  journal = {Cancer Chemotherapy and Pharmacology},
  year = {2024},
  volume = {94},
  number = {2},
  pages = {169--181},
  doi = {10.1007/s00280-024-04663-7}
}
Kostenlos starten →